T Cell Receptor Diversity among Non-Small Cell Lung Cancer Patients Treated with Pembrolizumab Alone or in Combination with Chemotherapy

A. Abed, A. Beasly, A. Reid, L. Calapre, M. Millward, E. Gray

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

Original language	English
Pages (from-to)	S555-S556
Number of pages	2
Journal	Journal of Thoracic Oncology
Volume	17
Issue number	9
Publication status	Published - Sept 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{240e164ef9b74270a1cbd15c1b23610e,

title = "T Cell Receptor Diversity among Non-Small Cell Lung Cancer Patients Treated with Pembrolizumab Alone or in Combination with Chemotherapy",

keywords = "T-Cell Receptor, Non-Small Cell Lung Cancer, Pembrolizumab",

author = "A. Abed and A. Beasly and A. Reid and L. Calapre and M. Millward and E. Gray",

year = "2022",

month = sep,

language = "English",

volume = "17",

pages = "S555--S556",

journal = "Journal of Thoracic Oncology",

issn = "1556-0864",

publisher = "Elsevier",

number = "9",

}

TY - JOUR

T1 - T Cell Receptor Diversity among Non-Small Cell Lung Cancer Patients Treated with Pembrolizumab Alone or in Combination with Chemotherapy

AU - Abed, A.

AU - Beasly, A.

AU - Reid, A.

AU - Calapre, L.

AU - Millward, M.

AU - Gray, E.

PY - 2022/9

Y1 - 2022/9

KW - T-Cell Receptor

KW - Non-Small Cell Lung Cancer

KW - Pembrolizumab

M3 - Abstract/Meeting Abstract

SN - 1556-0864

VL - 17

SP - S555-S556

JO - Journal of Thoracic Oncology

JF - Journal of Thoracic Oncology

IS - 9

ER -